4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-414684
Lyon Joseph Douglas sold 10,000 shares at an average $116.07 ($1,160,731)
- Lyon Joseph Douglas acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +810 | $13.56 | $10,984 | 6,493 | D |
| 2026-10-01 | Sale : show line 2 in the form 10b5-1 | −810 | $115.40 | $93,473 | 5,683 | D |
| 2026-10-02 | Exercise or conversion : show line 3 in the form 10b5-1 | +3,357 | $13.56 | $45,521 | 9,040 | D |
| 2026-10-02 | Exercise or conversion : show line 4 in the form 10b5-1 | +5,833 | $19.26 | $112,344 | 14,873 | D |
| 2026-10-02 | Sale : show line 5 in the form 10b5-1 | −4,446 | $115.70 | $514,389 | 10,427 | D |
| 2026-10-02 | Sale : show line 6 in the form 10b5-1 | −4,744 | $116.54 | $552,869 | 5,683 | D |
| Open-market sales · 10,000 sh · avg $116.07 · $1,160,731 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-01 | Exercise or conversion : show line 7 in the form 10b5-1 Stock option (right to buy) | −810 | 3,357 | D |
| 2026-10-02 | Exercise or conversion : show line 8 in the form 10b5-1 Stock option (right to buy) | −3,357 | 0 | D |
| 2026-10-02 | Exercise or conversion : show line 9 in the form 10b5-1 Stock option (right to buy) | −5,833 | 44,167 | D |
Loading xslF345X06/ownership.xml…